Search results
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 3 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 4 days agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) reported a mixed first quarter in 2024, with significant business...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks via Yahoo Finance· 5 days agoThis suggests that analysts have very recently bumped up their estimates for MRNA, giving the stock...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 7 days agoFree Report) is expected to reveal quarterly loss of $3.59 per share, indicating a decline of 1989.5% compared to the year-ago period. Over the past 30 days, the consensus EPS estimate for the ...
Stock Market Today: S&P 500 closes higher as tech leads charge; jobs report eyed By Investing.com
Investing.com· 4 days agoStock Market Today: S&P 500 closes higher as tech leads charge; jobs report eyed
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
Guru Focus· 2 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) filed its 10-Q report, revealing a challenging quarter with a stark decrease in revenue and a shift from profitability to a net ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 3 days agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 6 days agoWe've identified 1 warning sign for Moderna that investors should be aware of in a dynamic business...